KANGSTEM BIOTECH CO., LTD. financial statements, including revenue, expenses, and profit
The total revenue of 217730 for the last quarter is 3.40 B KRW, and it's 334.43% higher compared to the previous quarter. The net income of Q4 24 is -4.38 B KRW.